http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112516101-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12cf0bd151553ffa125d808475c99345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d4354c8f6e3bdcdd967a256b90464eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ac27e45e93e1ca094cd8c3c8108e3f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
filingDate 2020-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f246e07bfbbd5979a2ad77b73a0456c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dcd1ecb3a5e71e77bdb6309bd148544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13ee38c26263a205416a0e37d8f82b46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8fe281b7ed7be9a336077712a453475
publicationDate 2021-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112516101-A
titleOfInvention A kind of tablet containing quetiapine fumarate and preparation method thereof
abstract The present invention relates to a tablet containing quetiapine fumarate and a preparation method thereof. The tablet or its core comprises an active component quetiapine fumarate, internal auxiliary materials and external auxiliary materials. In the process, the active components are firstly pulverized, mixed with one or more internal-added auxiliary materials evenly, then a wetting agent is added for one-time granulation, the obtained wet granules are dried and then pulverized through a 50-15 mesh sieve, and mixed with the remaining internal-added auxiliary materials. Mix evenly, then add a wetting agent for secondary granulation, dry and granulate the wet granules obtained again; then mix with external auxiliary materials for tableting; wherein, the internal added auxiliary materials are fillers, binders and internal added disintegration. Additives are additional disintegrants and lubricants. The invention significantly solves the problems of low dissolution rate and incomplete dissolution at the end point caused by static electricity, aggregation, adsorption and high surface energy of large-scale insoluble preparation raw materials after pulverization through simple secondary granulation, and significantly improves the dissolution rate and efficiency. bioavailability.
priorityDate 2020-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25058200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454660180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419802379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12444276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239

Total number of triples: 62.